Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2055)
All Articles published online
|
Mar 21, 2008 (publication date) through Dec 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Maio MD, Daniele B, Pignata S, Gallo C, Maio ED, Morabito A, Piccirillo MC, Perrone F. Is human hepatocellular carcinoma a hormone-responsive tumor? World J Gastroenterol 2008; 14(11): 1682-1689 [PMID: 18350599 DOI: 10.3748/wjg.14.1682] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i11/1682.htm |
| Number | Citing Articles |
| 1 |
Karoly Szepeshazi, Norman L. Block, Andrew V. Schally. The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancers. hmbci 2010; 1(3): 103 doi: 10.1515/HMBCI.2010.018
|
| 2 |
Wen-Lung Ma, Cheng-Lung Hsu, Chun-Chieh Yeh, Ming-Heng Wu, Chiung-Kuei Huang, Long-Bin Jeng, Yao-Ching Hung, Tze-Yi Lin, Shuyuan Yeh, Chawnshang Chang. Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis. Hepatology 2012; 56(1): 176 doi: 10.1002/hep.25644
|
| 3 |
Woon‐Puay Koh, Jian‐Min Yuan, Renwei Wang, Sugantha Govindarajan, Rowena Oppenheimer, Zhen Quan Zhang, Mimi C. Yu, Sue Ann Ingles. Aromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis‐related hepatocellular carcinoma. Cancer 2011; 117(15): 3383 doi: 10.1002/cncr.25939
|
| 4 |
Reina Yao, Connie G Chiu, Scott S Strugnell, Sabrina Gill, Sam M Wiseman. Gender differences in thyroid cancer: a critical review. Expert Review of Endocrinology & Metabolism 2011; 6(2): 215 doi: 10.1586/eem.11.9
|
| 5 |
Cheng Ji. New Insights into the Pathogenesis of Alcohol-Induced ER Stress and Liver Diseases. International Journal of Hepatology 2014; 2014: 1 doi: 10.1155/2014/513787
|
| 6 |
Sithul Hima, Sreeharshan Sreeja. Modulatory role of 17β‐estradiol in the tumor microenvironment of thyroid cancer. IUBMB Life 2016; 68(2): 85 doi: 10.1002/iub.1462
|
| 7 |
Wen-Lung Ma, Hsueh-Chou Lai, Shuyuan Yeh, Xiujun Cai, Chawnshang Chang. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocrine-Related Cancer 2014; 21(3): R165 doi: 10.1530/ERC-13-0283
|
| 8 |
Giuseppe Carruba. Estrogens in Hepatocellular Carcinoma: Friends or Foes?. Cancers 2021; 13(9): 2085 doi: 10.3390/cancers13092085
|
| 9 |
Yongbing Zhao, Zhaoyu Li. Interplay of estrogen receptors and FOXA factors in the liver cancer. Molecular and Cellular Endocrinology 2015; 418: 334 doi: 10.1016/j.mce.2015.01.043
|
| 10 |
Yan Xia, Xianhao Liu, Beibei Liu, Xiaoshi Zhang, Geng Tian. Enhanced antitumor activity of combined megestrol acetate and arsenic trioxide treatment in liver cancer cells. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5905
|
| 11 |
Riccardo Nevola, Giovanni Tortorella, Valerio Rosato, Luca Rinaldi, Simona Imbriani, Pasquale Perillo, Davide Mastrocinque, Marco La Montagna, Antonio Russo, Giovanni Di Lorenzo, Maria Alfano, Maria Rocco, Carmen Ricozzi, Klodian Gjeloshi, Ferdinando Carlo Sasso, Raffaele Marfella, Aldo Marrone, Loreta Anesti Kondili, Nicolino Esposito, Ernesto Claar, Domenico Cozzolino. Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma. Biology 2023; 12(7): 984 doi: 10.3390/biology12070984
|
| 12 |
Eriko Tanabe, Ayano Shibata, Serina Inoue, Misaho Kitayoshi, Nobuyuki Fukushima, Toshifumi Tsujiuchi. Regulation of cell motile activity through the different induction of LPA receptors by estrogens in liver epithelial WB-F344 cells. Biochemical and Biophysical Research Communications 2012; 428(1): 105 doi: 10.1016/j.bbrc.2012.10.015
|
| 13 |
Luca Ielasi, Enrico Fulco, Nicola Reggidori, Marco Domenicali, Francesco Giuseppe Foschi. Anabolic Androgenic Steroids and Hepatocellular Adenoma and Carcinoma: Molecular Mechanisms and Clinical Implications. Gastroenterology Insights 2024; 15(3): 599 doi: 10.3390/gastroent15030044
|
| 14 |
Feras Y. Al-Rawashdeh, Peter Scriven, Ian C. Cameron, Patricia V. Vergani, Lynda Wyld. Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2010; 22(9): 1099 doi: 10.1097/MEG.0b013e3283378405
|
| 15 |
Chang Liu, Yi-Fan Ren, Jian Dong, Meng-Yun Ke, Feng Ma, Satdarshan P.S. Monga, Rongqian Wu, Yi Lv, Xu-Feng Zhang. Activation of SRY accounts for male-specific hepatocarcinogenesis: Implication in gender disparity of hepatocellular carcinoma. Cancer Letters 2017; 410: 20 doi: 10.1016/j.canlet.2017.09.013
|
| 16 |
Mamta Kalra, Jary Mayes, Senait Assefa, Anil K Kaul, Rashmi Kaul. Role of sex steroid receptors in pathobiology of hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(39): 5945-5961 doi: 10.3748/wjg.14.5945
|
| 17 |
Maimuna Mendy, Robert Walton. Molecular pathogenesis and early detection of hepatocellular carcinoma – Perspectives from West Africa. Cancer Letters 2009; 286(1): 44 doi: 10.1016/j.canlet.2009.04.039
|
| 18 |
Michele Vacca, Chiara Degirolamo, Vittoria Massafra, Lorenzo Polimeno, Renato Mariani-Costantini, Giuseppe Palasciano, Antonio Moschetta. Nuclear receptors in regenerating liver and hepatocellular carcinoma. Molecular and Cellular Endocrinology 2013; 368(1-2): 108 doi: 10.1016/j.mce.2012.06.025
|
| 19 |
Anna Giacomin, Adriana Sergio, Veronica Vanin, Pietro Tartaro, Daniela Paccagnella, Mauro Mazzucco, Fabio Farinati. Megestrol and embryonic extracts in the treatment of advanced hepatocellular carcinoma: A prospective randomized trial in the pre‐sorafenib era. Hepatology Research 2010; 40(2): 153 doi: 10.1111/j.1872-034X.2009.00588.x
|
| 20 |
Ahmed Abdelmabood Zeeneldin, Salem Mohamed Eid, Amira Diaa Darweesh, Manar Mohamed Moneer, Mohamed Saadeldin. Tamoxifen compared to best supportive care in advanced hepatocelluar carcinoma: A retrospective matched-cohort study. Journal of the Egyptian National Cancer Institute 2014; 26(1): 1 doi: 10.1016/j.jnci.2013.03.005
|
| 21 |
Maria Pia Costa-Santos, Afonso Gonçalves, Alexandre Oliveira Ferreira, Joana Nunes. Spontaneous regression of hepatocellular carcinoma: myth or reality?. BMJ Case Reports 2020; 13(2): e233509 doi: 10.1136/bcr-2019-233509
|
| 22 |
Philipp Solbach, Andrej Potthoff, Hans-Jürgen Raatschen, Bisharah Soudah, Ulrich Lehmann, Andrea Schneider, Michael J. Gebel, Michael P. Manns, Arndt Vogel. Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0288-0
|
| 23 |
Yuxiang Wan, Honglin Jiang, Zeyu Liu, Chen Bai, Yanyan Lian, Chunguang Zhang, Qiaoli Zhang, Jinchang Huang. Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic
Reprogramming of Hepatocellular Carcinoma: A Study based on Network
Pharmacology, Molecular Docking and Bioinformatics. Current Pharmaceutical Design 2024; 30(24): 1894 doi: 10.2174/0113816128287535240429043610
|
| 24 |
Catherine C. Cortright, Sharon A. Center, John F. Randolph, Sean P. McDonough, Kellie A. Fecteau, Karen L. Warner, Ann M. Chiapella, Rhonda L. Pierce, A. Heather Graham, Linda J. Wall, John H. Heidgerd, Melisa A. Degen, Patricia A. Lucia, Hollis N. Erb. Clinical features of progressive vacuolar hepatopathy in Scottish Terriers with and without hepatocellular carcinoma: 114 cases (1980–2013). Journal of the American Veterinary Medical Association 2014; 245(7): 797 doi: 10.2460/javma.245.7.797
|
| 25 |
Abudulimutailipu Nuermaimaiti, Le Chang, Ying Yan, Huizhen Sun, Yingzi Xiao, Shi Song, Kaihao Feng, Zhuoqun Lu, Huimin Ji, Lunan Wang. The role of sex hormones and receptors in HBV infection and development of HBV‐related HCC. Journal of Medical Virology 2023; 95(12) doi: 10.1002/jmv.29298
|
| 26 |
Sheng-Han Wang, Shiou-Hwei Yeh, Chung-Wai Shiau, Kuen-Feng Chen, Wei-Hsiang Lin, Ting-Fen Tsai, Yuan-Chi Teng, Ding-Shinn Chen, Pei-Jer Chen. Sorafenib Action in Hepatitis B Virus X–Activated Oncogenic Androgen Pathway in Liver through SHP-1. Journal of the National Cancer Institute 2015; 107(10): djv190 doi: 10.1093/jnci/djv190
|
| 27 |
Ali Alqahtani, Zubair Khan, Abdurahman Alloghbi, Tamer S. Said Ahmed, Mushtaq Ashraf, Danae M. Hammouda. Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies. Medicina 2019; 55(9): 526 doi: 10.3390/medicina55090526
|
| 28 |
Yuan-Yuan Zhang, Harry Hua-Xiang Xia. Novel therapeutic approaches for hepatocellulcar carcinoma: Fact and fiction. World Journal of Gastroenterology 2008; 14(11): 1641-1642 doi: 10.3748/wjg.14.1641
|
| 29 |
Yao-Tsung Yeh, Chien-Wei Chang, Ren-Jie Wei, Shen-Nien Wang. Progesterone and Related Compounds in Hepatocellular Carcinoma: Basic and Clinical Aspects. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/290575
|
| 30 |
Manal M. Hassan, Gehan Botrus, Reham Abdel-Wahab, Robert A. Wolff, Donghui Li, David Tweardy, Alexandria T. Phan, Ernest Hawk, Milind Javle, Ju-Seog Lee, Harrys A. Torres, Asif Rashid, Renato Lenzi, Hesham M. Hassabo, Yasmin Abaza, Ahmed S. Shalaby, Sahin Lacin, Jeffrey Morris, Yehuda Z. Patt, Christopher I. Amos, Saira A. Khaderi, John A. Goss, Prasun K. Jalal, Ahmed O. Kaseb. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology 2017; 15(11): 1791 doi: 10.1016/j.cgh.2017.05.036
|
| 31 |
Hong Zhang, Xiao‐Xing Li, Yang Yang, Yanjie Zhang, Hui‐Yun Wang, X.F. Steven Zheng. Significance and mechanism of androgen receptor overexpression and androgen receptor/mechanistic target of rapamycin cross‐talk in hepatocellular carcinoma. Hepatology 2018; 67(6): 2271 doi: 10.1002/hep.29715
|
| 32 |
|
| 33 |
Yalcin Erzurumlu, Hatice Kubra Dogan, Deniz Cataklı. Dexamethasone-stimulated glucocorticoid receptor signaling positively regulates the endoplasmic reticulum-associated degradation (ERAD) mechanism in hepatocellular carcinoma cells. Steroids 2023; 195: 109238 doi: 10.1016/j.steroids.2023.109238
|
| 34 |
Xiaotian Chang, Jinxiang Han, Li Pang, Yan Zhao, Yi Yang, Zhonglin Shen. Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-40
|
| 35 |
Cho Naing, Han Ni, Htar Htar Aung. Tamoxifen for adults with hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2024; 2024(8) doi: 10.1002/14651858.CD014869.pub2
|
| 36 |
Arjumand S. Warsy, Fatimah Basil Almukaynizi, Soad AlDaihan, Sophia Alam, Maha Daghastani. Genetic Polymorphisms. 2017; doi: 10.5772/intechopen.69208
|
| 37 |
Lichun Wang, Azhar Rasul, Zili Liu, Ying Pan, Weihua Wang, Jiang Li, Xiaomeng Li. The Loss of Masculine With Declined Serum DHT Is Associated With High Risk of Hepatocellular Carcinoma in Chinese Men. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00362
|